Subscribe
27 November 2025FeaturesBig PharmaAmanda Simons

The clinical trial dilemma: Navigating European practice

Clinical trials create a patent paradox. With EPO case law rapidly reshaping the 'expectation of success' test—most recently T136/24—the line between innovation and obviousness is blurred. Amanda Simons of J A Kemp offers drafting strategies to secure protection for your downstream innovations.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
WATCH: Evergreening (or life cycle management patents—including polymorphs and patents arising from clinical trial data
29 May 2025   Ravi Srinivasan of JA Kemp explores strategies for identifying, prosecuting, and defending follow-on patent applications after a therapeutic product enters the public domain. The session at LSPN covers patents based on clinical trial data and polymorphs of small molecule drugs.
Americas
WATCH: Essential considerations: patenting and clinical trials
23 November 2024   There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries. Safeguarding your innovation throughout the research process is critical, necessitating a careful balance between the need to file and when to file, explain speakers from IGM Biosciences, IP Recor Medical, and Sanaria Inc.


Editor's picks

Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
Europe
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
25 November 2025

Editor's picks

Europe
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
25 November 2025
Americas
INTA votes in new 2026 president at Florida leadership meeting
20 November 2025
Asia
WIPR Rankings reveals the go-to firms and attorneys for China patent work
7 November 2025
Americas
New AIPLA president calls for greater certainty in US patent law
6 November 2025
Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025
Americas
Squires: ‘Inherited patent backlog was an absolute dumpster fire’
1 November 2025

More features

Novartis counsel on managing patents at a $50bn company
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
Use of genAI to draft patents ‘a big concern’: CIPA’s AI chair
Still Unsettling: The uncertain landscape for discretionary denial
What people talked about at London Life Sciences Week
NHS updates outdated IP rules in bid to revive UK life sciences
MSD wins full sweep in world’s best-selling drug clash
Report reveals surge of AI adoption in IP but lawyers remain cautious